Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dare Bioscience Inc (NQ: DARE )

1.000 -0.010 (-0.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,799
Open 1.000
Bid (Size) 0.9900 (36)
Ask (Size) 1.020 (11)
Prev. Close 1.010
Today's Range 1.000 - 1.040
52wk Range 0.9201 - 2.510
Shares Outstanding 70,521,979
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Outlook For Dare Bioscience
  Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Dare... 
Via Benzinga

Performance

YTD
-52.15%
-52.15%
1 Month
-7.41%
-7.41%
3 Month
-15.97%
-15.97%
6 Month
-41.52%
-41.52%
1 Year
-40.12%
-40.12%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
President Biden Mulls Health Emergency For Abortion Access: Report
Via Benzinga
Dare Bioscience: Q1 Earnings Insights
Via Benzinga
Recap: Dare Bioscience Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision
Via InvestorPlace
3 Women's Health Stocks Are Soaring Following Roe v. Wade Ruling
Via Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Via Benzinga
Earnings Preview: Dare Bioscience
Via Benzinga
Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment
Via Benzinga
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
From Organon & Co.
Via Business Wire
Earnings Scheduled For March 31, 2022
Via Benzinga
Earnings Preview: Dare Bioscience
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Exposures Product Safety
35 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today?
Via InvestorPlace
BZ Chart Of The Day: Dare Bioscience
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.